Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study-Reference-Cited by-同舟云学术

Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study

Published:2024-05 Issue:5 Volume:153 Page:1423-1431.e2
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Grunebaum Eyal^ORCID,Arnold Danielle E.,Logan Brent,Parikh Suhag,Marsh Rebecca A.,Griffith Linda M.,Mallhi Kanwaldeep,Chellapandian Deepak,Lim Stephanie Si,Deal Christin L.,Kapoor Neena,Murguía-Favela Luis,Falcone Emilia Liana,Prasad Vinod K.,Touzot Fabien,Bleesing Jack J.,Chandrakasan Shanmuganathan,Heimall Jennifer R.,Bednarski Jeffrey J.,Broglie Larisa A.,Chong Hey Jin,Kapadia Malika,Prockop Susan,Dávila Saldaña Blachy J.,Schaefer Edo,Bauchat Andrea L.,Teira Pierre,Chandra Sharat,Parta Mark,Cowan Morton J.,Dvorak Christopher C.,Haddad Elie,Kohn Donald B.,Notarangelo Luigi D.,Pai Sung-Yun,Puck Jennifer M.,Pulsipher Michael A.,Torgerson Troy R.,Malech Harry L.,Kang Elizabeth M.,Leiding Jennifer W.

Funder

National Institutes of Health

Office of Naval Research

Health Resources and Services Administration

California Institute for Regenerative Medicine

NCATS

National Institute of Allergy and Infectious Diseases Vaccine Research Center

The Hospital for Sick Children

National Cancer Institute

NIAID

National Heart Lung and Blood Institute

Publisher